Oritavancin polymethylmethacrylate (PMMA)-compressive strength testing and in vitro elution

Silver nanoparticles can be sampled by ultrafiltration probe but elution into & recovery from plasma and Dulbecco's Phosphate Buffered Saline differs in vitro

Locally sustained release antimicrobials such as silver nanoparticles (AgNPs) might prove useful in combating local infections. Their elution has been investigated in Phosphate Buffered Saline (PBS) including from poloxamer 407 (P407). No information exists on possible interactions with proteins, nor have ultrafiltration (UF) probes been evaluated to measure Ag. These investigations would provide helpful data prior to investigating the sustained release after subcutaneous implantation in vivo over time. We compared (1) the influence of elution fluid on AgNP elution, and (2) UF probe and direct sampling in vitro. Six AgNP-P407 specimens in a dialysis tube were placed in Dulbecco's PPBS (DPBS) (n = 3) or canine plasma (n = 3) for 96 h on a stirred hot plate (37 °C and 600 rpm) and sampled 20 times. A 0.001 mg/mL AgNP solution was prepared in DPBS or plasma. Six pipette and UF probe samples were taken of each. Inductively coupled plasma mass spectrometry was used to analyze Ag. Stock plasma contained Ag. At 96 h, 5/6 dialysis tubes had not fully released AgNP. One peak in hourly Ag increase was present in DPBS (10-13 h), and two peaks in plasma (6-8 and 10-13 h). The hourly Ag increase in plasma decreased earlier than in DPBS. Ultrafiltration probe sampling was possible in both DPBS and plasma and resulted in higher Ag concentrations but with more variation. While in vitro use of DPBS might be more cost effective, plasma should be considered due to difference in elution and recovery. Ultrafiltration probes can be used to sample Ag, but results will have a greater degree of variation, and multiple samples and increased time points should be considered.

Cure State Sensing of Polymethylmethacrylate Using a Vibrating Axial Probe

A new axially vibrating sensor based on an audio voice coil transducer and a lead zirconate titanate (PZT) piezoelectric disc microphone was developed as a probe for the measurement of in vitro rheological fluid properties, including curing progress for polymethylmethacrylate (PMMA) mixtures with important uses as bone cement in the field of orthopedics. The measurement of the vibrating axial sensor's acoustic spectra in PMMA undergoing curing can be described by a damped harmonic oscillator formalism and resonant frequency (ca. 180 Hz) shift can be used as an indicator of curing progress, with shifts to the blue by as much as 14 Hz. The resonant frequency peak was measured in 19 different 4.0 g PMMA samples to have a rate of shift of 0.0462 ± 0.00624 Hz·s-1 over a period of 400 s while the PMMA was in a dough state and before the PMMA transitioned to a hard-setting phase. This transition is unambiguously indicated by this sensor technology through the generation of a distinct circa 5 kHz high-Q under-damped ring-down response.

A dual PMMA/calcium sulfate carrier of vancomycin is more effective than PMMA-vancomycin at inhibiting Staphylococcus aureus growth in vitro

Both antibiotic-impregnated poly(methyl acrylate, methyl methacrylate) (PMMA) and antibiotic-impregnated calcium sulfate have been successfully used as local antibiotic delivery vehicles for the management of chronic osteomyelitis. Here, we examined the antibiotic elution characteristics and antibacterial properties of a composite drug delivery system consisting of PMMA/calcium sulfate carrying vancomycin (dual carrier-v) against Staphylococcus aureus, with PMMA loaded with vancomycin (PMMA-v) as a control. Vancomycin gradually degraded from dual carrier-v and PMMA-v up to about 8 and 6 weeks, respectively. At different elution time points, the inhibition zones of the dual carrier-v were larger than the inhibition zones of the PMMA-v (P < 0.05). The colony inhibition rate of the dual carrier-v was 95.57%, whereas it was 77.87% for PMMA-v. Scanning electron microscopy was used to demonstrate biofilm formation on the surface of plates treated with vancomycin-unloaded PMMA, whereas there was no biofilm formation on the surface of plates treated with dual carrier-v or PMMA-v. The dual carrier-v was more effective at antibacterial adhesion at each time point after immersion in simulated body fluid as compared with PMMA-v (P < 0.05). In conclusion, our results suggest that the dual carrier-v can release higher concentrations of antibiotics and inhibit bacteria growth more effectively in vitro as compared with PMMA-v. The dual carrier-v thus may have potential as an alternative strategy for osteomyelitis management.